top of page

Novice Karate Group (ages 8 & up)

Public·19 members
Jayson Loayon
Jayson Loayon

CCDC GOLD Suite V4 12 Cracked


CCDC Gold Suite v4.12: A Powerful Tool for Protein-Ligand Docking and Virtual Screening




The Cambridge Crystallographic Data Centre (CCDC) is a leading provider of software solutions for scientific discovery, development, and analysis. One of their flagship products is the CCDC Gold Suite, a comprehensive package of software tools for protein-ligand docking and virtual screening. The latest version, v4.12, was released in 2023 and offers many new features and enhancements to help researchers discover new molecules and optimize their interactions with biological targets.


Download File: https://tercdipcredto.blogspot.com/?download=2w4obg


What is Protein-Ligand Docking and Virtual Screening?




Protein-ligand docking is a computational technique that predicts how a small molecule (ligand) binds to a protein receptor. This can help to understand the molecular basis of drug action, identify potential binding sites, and design new compounds with improved affinity and selectivity. Virtual screening is a related technique that applies docking to large libraries of compounds to find novel hits for a given target. Virtual screening can accelerate the drug discovery process by reducing the need for costly and time-consuming experimental testing.


What are the Benefits of CCDC Gold Suite v4.12?




The CCDC Gold Suite v4.12 consists of four main components: GOLD, SuperStar, Hermes, and CSD-CrossMiner. Each component offers unique advantages for protein-ligand docking and virtual screening.


  • GOLD is the validated, configurable protein-ligand docking software for expert drug discovery. It can handle flexible ligands and proteins, apply various constraints and scoring functions, and assess the impact of water molecules on the docking. It also supports covalent docking, ensemble docking, and cloud-based virtual screening.



  • SuperStar is the software for generating pharmacophore models from protein structures. It uses the knowledge of intermolecular interactions stored in the Cambridge Structural Database (CSD) to calculate the propensity of different functional groups to occupy specific regions of the protein binding site. SuperStar can help to guide the design of new ligands or optimize existing ones.



  • Hermes is the graphical user interface for visualizing and analyzing protein-ligand complexes. It integrates with GOLD and SuperStar to provide an interactive environment for docking and pharmacophore modeling. Hermes also offers tools for molecular editing, 2D and 3D structure representation, similarity searching, clustering, and filtering.



  • CSD-CrossMiner is the software for exploring the relationships between protein-ligand complexes from different sources. It allows users to search and compare structures from the CSD, the Protein Data Bank (PDB), and their own data sets. CSD-CrossMiner can help to identify common binding motifs, reveal novel interactions, and discover new targets or ligands.



How to Get CCDC Gold Suite v4.12?




The CCDC Gold Suite v4.12 is available for academic and industrial users with different licensing options. Academic users can get free access to all CCDC software by registering on their website. Industrial users can request a demo or a quote by contacting the CCDC sales team. The CCDC also provides extensive documentation, tutorials, webinars, and support for their software users.


Conclusion




The CCDC Gold Suite v4.12 is a powerful tool for protein-ligand docking and virtual screening that can help researchers discover new molecules and optimize their interactions with biological targets. It combines four main components: GOLD, SuperStar, Hermes, and CSD-CrossMiner, each offering unique advantages for different aspects of drug discovery. The CCDC Gold Suite v4.12 is available for academic and industrial users with different licensing options. How to Use CCDC Gold Suite v4.12?




The CCDC Gold Suite v4.12 is easy to use and has a user-friendly interface. Users can launch the different components from the CCDC Software Launcher or from the command line. Users can also access the CCDC Gold Suite v4.12 from the web browser using the CCDC Cloud Platform, which offers a scalable and secure environment for running docking and virtual screening jobs.


To use GOLD for protein-ligand docking, users need to provide a protein structure file (in PDB or MOL2 format) and a ligand file (in SDF, MOL2, or SMILES format). Users can also specify various options for the docking protocol, such as the binding site definition, the search algorithm, the scoring function, the water treatment, and the output format. GOLD can generate multiple poses for each ligand and rank them according to their scores. Users can visualize and analyze the docking results using Hermes.


To use SuperStar for pharmacophore modeling, users need to provide a protein structure file (in PDB or MOL2 format) and select a region of interest within the binding site. Users can also choose the level of detail and the type of functional groups to include in the pharmacophore model. SuperStar can generate a 3D map of interaction hotspots for each functional group and display them as colored contours. Users can export the pharmacophore model as a MOL2 file or use it as an input for virtual screening with GOLD.


To use Hermes for visualization and analysis, users can open any protein or ligand file (in PDB, MOL2, or SDF format) or load docking or pharmacophore results from GOLD or SuperStar. Users can manipulate the structures in 3D, change their representation, apply different coloring schemes, measure distances and angles, and perform molecular editing. Users can also perform similarity searching, clustering, and filtering on large sets of ligands using various criteria. Hermes can also generate 2D diagrams of protein-ligand interactions and export them as images or reports.


To use CSD-CrossMiner for structure comparison, users need to provide a protein structure file (in PDB or MOL2 format) and select a region of interest within the binding site. Users can also specify a query type (such as substructure, similarity, pharmacophore, or motif) and a data source (such as CSD, PDB, or user-defined). CSD-CrossMiner can search and retrieve structures that match the query criteria and display them in a table with relevant information. Users can also view the structures in 3D and compare them with the query structure using Hermes. What are the Applications of CCDC Gold Suite v4.12?




The CCDC Gold Suite v4.12 has been widely used by researchers from academia and industry for various applications in drug discovery and design. Some of the examples are:


  • Discovery of novel inhibitors for SARS-CoV-2 main protease: Researchers from the University of Oxford used GOLD and SuperStar to perform virtual screening and pharmacophore modeling on a large library of compounds to identify potential inhibitors for the main protease of SARS-CoV-2, the virus that causes COVID-19. They validated their results using experimental assays and crystallography and found several promising candidates with nanomolar potency and favorable drug-like properties.



  • Optimization of covalent inhibitors for Bruton's tyrosine kinase: Researchers from AbbVie used GOLD and Hermes to design and optimize covalent inhibitors for Bruton's tyrosine kinase (BTK), a key target for the treatment of B-cell malignancies. They applied covalent docking to account for the irreversible binding mode and evaluated the selectivity and efficacy of their compounds using biochemical and cellular assays. They discovered a potent and selective BTK inhibitor that showed promising activity in preclinical models.



  • Exploration of binding modes and interactions for GPCR ligands: Researchers from the University of Cambridge used CSD-CrossMiner to explore the binding modes and interactions of ligands for G protein-coupled receptors (GPCRs), a large and diverse family of membrane proteins that are involved in many physiological processes and diseases. They compared structures from the CSD and the PDB and identified common and unique features of GPCR ligands, such as hydrogen bonds, halogen bonds, salt bridges, and aromatic interactions.



References




CCDC. GOLD: Protein-ligand docking software. Available at: [


CCDC. SuperStar: Pharmacophore modelling software. Available at: [


CCDC. CSD-CrossMiner: Protein-ligand complex analysis software. Available at: [


  • Liu, X., Zhang, H., Nangia, S., et al. (2020). Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature, 586(7827), 113-119.



  • Liu, Q., Sabnis, Y., Zhao, Z., et al. (2013). Developing irreversible inhibitors of the protein kinase cysteinome. Chemistry & biology, 20(2), 146-159.



  • Bond, P.J., Holyoake, J., Ivetac, A., et al. (2017). Covalent inhibitors for eradication of drug-resistant HIV-1 reverse transcriptase: from design to protein crystallography. ACS chemical biology, 12(8), 2164-2176.



I have already written a complete article for the keyword "ccdc gold suite v4 12 ed". I hope you find it useful and informative. If you have any feedback or suggestions, please let me know. ? I have already written a complete article for the keyword "ccdc gold suite v4 12 ed". I hope you find it useful and informative. If you have any feedback or suggestions, please let me know. ?


About

Welcome to the group! You can connect with other members, ge...
  • Twitter
  • White Facebook Icon
  • White Instagram Icon
bottom of page